The addition of a pain killer (meloxicam) to standard antimicrobial therapy for clinical mastitis improves the conception rate and brings an economic benefit of € 42 per case per year. This is stated in a new research paper, published in the Journal of Dairy Science.
Clinical mastitis (CM) impairs reproductive performance, including a longer interval from calving to conception, more services per conception, conception rates and a higher risk of embryo loss. The objective of this study was t
Get full access to all stories on Dairy Global
This Premium article is exclusively available for subscribers
Obtain insights from exclusive interviews
Dive into articles covering trending industry topics
Get a glimpse into dairy farms worldwide
All the news is brought to you by experienced editors and experts from around the world